This is the newest newsletter of COST Action Glioma MR Imaging 2.0.
In this newsletter, we would like to remind you that GliMR has open ITC, STSM and VNT grants – we highly encourage everyone to apply. You can also find some save the dates, and a highlight on the recently published review from WG3. Finally, are proud to introduce our new Social Media Manager: Ivar Wamelink.
If you have any updates that you would like to share with GliMR, please email WG5. Don’t forget to follow us on
Save the date
31 March 2022 – 16h00 (CET): Webinar “7T MRI – What is going on inside of the subject?” (Online) – REGISTER NOW
25 – 27 July 2022: Training School “Artificial Intelligence in Neuro-oncology” (University College Dublin, Ireland)
28 – 30 September 2022: GliMR Annual Meeting in Tallinn (Estonia)
“7T MRI – What is going on inside of the subject?”
Dr. Gilber Hangel (Medical University of Vienna, Austria) will introduce us into the world of 7T.
Scans at 7T can cause side-effects not observed at lower fields. This talk will discuss what to expect of biological effects of 7 Tesla and the implications for subject safety and comfort. This includes sensory effects, implants and cognition as well as a few interesting digressions into biophysics.
NEW!! ‘Virtual Mobility Grants’ CALL OPEN – Deadline 31 March 22
Work together with another lab to exchange knowledge, learn new techniques, or collaborate on a project, using a virtual setting. This ranges from working on surveys, discussing research results, developing a blogging area, to organising workshops, webinars, or virtual exhibitions. More information and application via our website.
WG3 is proud to announce the publication of their systematic review on the use of advanced MR imaging to evaluate cancer-therapy-related damage to normal brain tissue.
With this review, GliMR hopes to encourage and guide less experienced users in selecting and designing future experiments for cancer-therapy monitoring using metabolic and physiological imaging. Read the full story here.
Can you bring GliMR from 2.0 to 200?
GliMR is growing to become a grand network, with 192 members from over 32 countries! However, we want to reach the magical number 200.
Therefore, we organise a small competition. The GliMR member that introduces member nr 200, wins the opportunity to present his/her work on one of our upcomming events or webinars. Introduce your colleague via e-mail.
Do you know preclinical researchers?
Currently, our community mostly exists from clinicians, physicist and engineers, leading to a abundance of technical and clinical knowledge and expertise. However, the preclinical field is not yet represented within our community, and we want to change that!
Therefore, we plan a session on preclinical work during our next GliMR meeting, but we need your help. Do you know researchers working on advanced MR for glioma in lab animals? Approach them, explain them what we do and introduce them to our community via e-mail!
Researcher of the Month
Ivar Wamelink is a PhD student at the Radiology and Nuclear Medicine department of the VUmc Amsterdam in the Netherlands. Before starting his PhD, he studied Technical Medicine in Enschede where he followed the Medical Imaging and Intervention track during his masters. During his final internship at the NKI, he started to appreciate the complex structure of the brain and got intrigued by the realm of artificial intelligence and the field of deep learning. The focus of his PhD project is to reduce the use of gadolinium contrast agents by combining novel AI methods with new advanced MRI techniques.
Congratulations to our Researcher of the Month: Dr. Saritha Unnikrishnan. Dr. Saritha Unnikrishnan Dr. Saritha Unnikrishnan is a lecturer in the department of Computing and Electronics at the Atlantic Technological University (ATU) Sligo, Ireland. She received her B. Tech....
The month of March came to a remarkable end with the insightful GliMR webinar in which Dr. Gilbert Hangel talked about 7T MRI and its effects on the subject. His talk covered practical aspects of installing and performing patient studies with a...
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
This COST Action aims to build a pan-European and multidisciplinary network of international experts in glioma research, patient organisations, data scientists, and MR imaging scientists by uniting the glioma imaging community within Europe and progressing the development and application of advanced MR imaging for improved decision making in diagnosis, patient monitoring, and assessment of treatment response in clinical trials and clinical practice.